SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Procter & Gamble Co. – ‘10-Q’ for 9/30/22 – ‘EX-32.1’

On:  Wednesday, 10/19/22, at 4:16pm ET   ·   For:  9/30/22   ·   Accession #:  80424-22-102   ·   File #:  1-00434

Previous ‘10-Q’:  ‘10-Q’ on 4/20/22 for 3/31/22   ·   Next:  ‘10-Q’ on 1/19/23 for 12/31/22   ·   Latest:  ‘10-Q’ on 4/19/24 for 3/31/24   ·   8 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

10/19/22  Procter & Gamble Co.              10-Q        9/30/22   51:4.9M

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Fy2223 Q1 Jas 10-Q                                  HTML   1.06M 
 2: EX-31.1     Rule 13A-14(A)/15D-14(A) Certification Chief        HTML     21K 
                Executive Officer                                                
 3: EX-31.2     Rule 13A-14(A)/15D-14(A) Certification Chief        HTML     21K 
                Financial Officer                                                
 4: EX-32.1     Section 1350 Certifications Chief Executive         HTML     18K 
                Officer                                                          
 5: EX-32.2     Section 1350 Certifications Chief Financial         HTML     17K 
                Officer                                                          
11: R1          Document and Entity Information                     HTML    108K 
12: R2          Consolidated Statements of Earnings                 HTML     92K 
13: R3          Condolidated Statements of Comprehensive Income     HTML     51K 
14: R4          Consolidated Balance Sheets                         HTML    138K 
15: R5          Consolidated Statements of Shareholders' Equity     HTML     89K 
16: R6          Consolidated Statements of Cash Flows               HTML     95K 
17: R7          Basis of Presentation                               HTML     19K 
18: R8          New Accounting Pronouncements and Policies          HTML     30K 
19: R9          Segment Information                                 HTML     70K 
20: R10         Goodwill and Other Intangible Assets                HTML     51K 
21: R11         Earnings Per Share                                  HTML     42K 
22: R12         Share-Based Compensation and Postretirement         HTML     25K 
                Benefits                                                         
23: R13         Risk Management Activities and Fair Value           HTML     64K 
                Measurements                                                     
24: R14         Accumulated Other Comprehensive Income (Loss)       HTML     38K 
25: R15         Commitments and Contingencies                       HTML     22K 
26: R16         Segment Reporting (Tables)                          HTML     64K 
27: R17         Goodwill and Other Intangible Assets (Tables)       HTML     51K 
28: R18         Earnings Per Share (Tables)                         HTML     41K 
29: R19         Share-Based Compensation and Postretirement         HTML     24K 
                Benefits (Tables)                                                
30: R20         Risk Management Activities and Fair Value           HTML     66K 
                Measurements (Tables)                                            
31: R21         Accumulated Other Comprehensive Income (Loss)       HTML     36K 
                (Tables)                                                         
32: R22         Segment Information - Sales (Details)               HTML     45K 
33: R23         Segment Information (Details)                       HTML     52K 
34: R24         Goodwill and Other Intangible Assets - Change in    HTML     39K 
                the Net Carrying Amount of Goodwill by Global                    
                Business Unit (Details)                                          
35: R25         Goodwill and Other Intangible Assets -              HTML     26K 
                Identifiable Intangible Assets (Details)                         
36: R26         Goodwill and Other Intangible Assets - Fair Value   HTML     26K 
                Sensitivity (Details)                                            
37: R27         Goodwill and Other Intangible Assets - Additional   HTML     30K 
                Information (Details)                                            
38: R28         Earnings Per Share (Details)                        HTML     71K 
39: R29         Earnings Per Share - Antidilutive Securities        HTML     21K 
                (Details)                                                        
40: R30         Share-Based Compensation and Postretirement         HTML     27K 
                Benefits (Details)                                               
41: R31         Risk Management Activities and Fair Value           HTML     38K 
                Measurements - Schedule of Derivative Instruments                
                (Details)                                                        
42: R32         Risk Management Activities and Fair Value           HTML     28K 
                Measurements - Derivative Instruments, Effect on                 
                Other Comprehensive Income (Loss) (Details)                      
43: R33         Risk Management Activities and Fair Value           HTML     25K 
                Measurements - Derivative Instruments Gain (Loss)                
                (Details)                                                        
44: R34         Risk Management Activities and Fair Value           HTML     42K 
                Measurements - Additional Information (Details)                  
45: R35         Accumulated Other Comprehensive Income (Loss) -     HTML     57K 
                Changes in Aoci and Reclassification Out of Aoci                 
                (Details)                                                        
46: R36         Commitments and Contingencies - Additional          HTML     27K 
                Information (Details)                                            
49: XML         IDEA XML File -- Filing Summary                      XML     86K 
47: XML         XBRL Instance -- pg-20220930_htm                     XML   1.23M 
48: EXCEL       IDEA Workbook of Financial Reports                  XLSX     78K 
 7: EX-101.CAL  XBRL Calculations -- pg-20220930_cal                 XML    126K 
 8: EX-101.DEF  XBRL Definitions -- pg-20220930_def                  XML    432K 
 9: EX-101.LAB  XBRL Labels -- pg-20220930_lab                       XML   1.01M 
10: EX-101.PRE  XBRL Presentations -- pg-20220930_pre                XML    579K 
 6: EX-101.SCH  XBRL Schema -- pg-20220930                           XSD    103K 
50: JSON        XBRL Instance as JSON Data -- MetaLinks              294±   420K 
51: ZIP         XBRL Zipped Folder -- 0000080424-22-000102-xbrl      Zip    272K 


‘EX-32.1’   —   Section 1350 Certifications Chief Executive Officer


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  

EXHIBIT 32.1
Section 1350 Certifications
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of The Procter & Gamble Company (the “Company”) certifies to his knowledge that:
(1)The Quarterly Report on Form 10-Q of the Company for the quarterly period ended September 30, 2022 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in that Form 10-Q fairly presents, in all material respects, the financial conditions and results of operations of the Company.

/s/ JON R. MOELLER
(Jon R. Moeller)
Chairman of the Board, President and Chief Executive Officer
October 19, 2022
Date
A signed original of this written statement required by Section 906 has been provided to The Procter & Gamble Company and will be retained by The Procter & Gamble Company and furnished to the Securities and Exchange Commission or its staff upon request.



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:10/19/228-K
For Period end:9/30/22
 List all Filings 


7 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/26/23  Procter & Gamble Co.              424B5                  2:464K                                   Donnelley … Solutions/FA
 4/24/23  Procter & Gamble Co.              424B5                  1:417K                                   Donnelley … Solutions/FA
 2/28/23  Procter & Gamble Co.              S-8         2/28/23    7:8.8M
 1/31/23  Procter & Gamble Co.              424B5                  2:409K                                   Donnelley … Solutions/FA
 1/27/23  Procter & Gamble Co.              424B5                  1:388K                                   Donnelley … Solutions/FA
 1/25/23  Procter & Gamble Co.              424B5                  2:448K                                   Donnelley … Solutions/FA
 1/23/23  Procter & Gamble Co.              424B5                  1:406K                                   Donnelley … Solutions/FA


1 Previous Filing that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/09/16  Procter & Gamble Co.              10-K        6/30/16  128:17M
Top
Filing Submission 0000080424-22-000102   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 1:15:42.1pm ET